The present invention relates to polyhydroxylated benzophenone compounds useful in the treatment of neurodegenerative, neurological, psychiatric, and cognitive diseases, in particular those associated with a deficiency in HDAC1 deacetylase activity.
本发明涉及聚羟基苯
酮类化合物,其在治疗神经退行性、神经学、精神病和认知疾病中有用,特别是那些与H
DAC1脱乙酰化酶活性缺乏有关的疾病。